Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Current Research on the Human Experience of Spirituality Following the Ingestion of ‘Magic’ Psilocybin Mushrooms: An Annotated Bibliography for Social Workers and Other Health Care Professionals

Rose Jade

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (45)

  1. Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. 2013-11-01 · Expand citations
  2. The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. 2013-01-01 · Expand citations
  3. Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. 2012-12-01 · Expand citations
  4. Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. 2012-06-01 · Expand citations
  5. Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. 2012-03-01 · Expand citations
  6. Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments. 2012-03-01 · Expand citations
  7. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. 2012-02-07 · Expand citations
  8. Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. 2012-02-01 · Expand citations
  9. Prediction of psilocybin response in healthy volunteers. 2012-01-01 · Expand citations
  10. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. 2011-12-01 · Expand citations
  11. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. 2011-11-01 · Expand citations
  12. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. 2011-11-01 · Expand citations
  13. Enzyme-assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushrooms 2011-09-01 · Expand citations
  14. Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring. 2011-02-02 · Expand citations
  15. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  16. Psychometric evaluation of the altered states of consciousness rating scale (OAV). 2010-08-31 · Expand citations
  17. Effects of Psilocybe argentipes on marble-burying behavior in mice. 2009-08-01 · Expand citations
  18. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. 2008-08-01 · Expand citations
  19. The Phenomenology and Potential Religious Import of States of Consciousness Facilitated by Psilocybin 2008-01-01 · Expand citations
  20. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
  21. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. 2006-08-01 · Expand citations
  22. Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. 2006-07-05 · Expand citations
  23. Skinner, Maslow, and Psilocybin 1993-07-01 · Expand citations
  24. OpenAlex W1830221852
  25. OpenAlex W2009122980
  26. OpenAlex W2012326074
  27. OpenAlex W2016549521
  28. OpenAlex W2030862796
  29. OpenAlex W2065709949
  30. OpenAlex W2075352853
  31. OpenAlex W2075760129
  32. OpenAlex W2080123927
  33. OpenAlex W2083420582
  34. OpenAlex W2089436854
  35. OpenAlex W2113099805
  36. OpenAlex W2117834601
  37. OpenAlex W2170811861
  38. OpenAlex W2321134670
  39. OpenAlex W2798640434
  40. OpenAlex W3021947875
  41. OpenAlex W4235632718
  42. OpenAlex W566218762
  43. OpenAlex W592476765
  44. OpenAlex W649756991
  45. OpenAlex W658045

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.